scholarly journals Clinical Efficacy of Fidarestat, a Novel Aldose Reductase Inhibitor, for Diabetic Peripheral Neuropathy: A 52-week multicenter placebo-controlled double-blind parallel group study

Diabetes Care ◽  
2001 ◽  
Vol 24 (10) ◽  
pp. 1776-1782 ◽  
Author(s):  
N. Hotta ◽  
T. Toyota ◽  
K. Matsuoka ◽  
Y. Shigeta ◽  
R. Kikkawa ◽  
...  
Keyword(s):  
Peripheral Neuropathy ◽  
Aldose Reductase ◽  
Clinical Efficacy ◽  
Diabetic Peripheral Neuropathy ◽  
Reductase Inhibitor ◽  
Aldose Reductase Inhibitor ◽  
Double Blind ◽  
Parallel Group Study ◽  
Parallel Group

Diabetic Peripheral Neuropathy: Effect of An Aldose Reductase Inhibitor

1983 ◽  
Vol 65 (3) ◽  
pp. 19P-20P
Author(s):  
I.G. Lewin ◽  
I.A.D. O'Brien ◽  
M.H. Morgan ◽  
R.J.M. Corrall
Keyword(s):  
Peripheral Neuropathy ◽  
Aldose Reductase ◽  
Diabetic Peripheral Neuropathy ◽  
Reductase Inhibitor ◽  
Aldose Reductase Inhibitor

The effects of zenarestat, an aldose reductase inhibitor, on peripheral neuropathy in Zucker diabetic fatty rats

Metabolism ◽  
2000 ◽  
Vol 49 (11) ◽  
pp. 1395-1399 ◽  
Author(s):  
Yukinori Shimoshige ◽  
Kyoko Ikuma ◽  
Tadashi Yamamoto ◽  
Shoji Takakura ◽  
Ikuo Kawamura ◽  
...  
Keyword(s):  
Peripheral Neuropathy ◽  
Aldose Reductase ◽  
Reductase Inhibitor ◽  
Aldose Reductase Inhibitor ◽  
Zucker Diabetic Fatty Rats
Sign in / Sign up

Export Citation Format

Share Document